{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:56:21Z","timestamp":1758048981386,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbrc.2022.03.079","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T03:00:21Z","timestamp":1647486021000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pigment epithelium-derived factor engineered to increase glycosaminoglycan affinity while maintaining bioactivity"],"prefix":"10.1016","volume":"605","author":[{"given":"Hunghao","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan T.","family":"Rebustini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-4983","authenticated-orcid":false,"given":"S. Patricia","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.03.079_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100921","article-title":"Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases","volume":"83","author":"Campochiaro","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2022.03.079_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12886-019-1208-9","article-title":"Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources","volume":"19","author":"Daien","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.bbrc.2022.03.079_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4239\/wjd.v7.i16.333","article-title":"Treatment of diabetic retinopathy: recent advances and unresolved challenges","volume":"7","author":"Stewart","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbrc.2022.03.079_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.17-22259","article-title":"Pharmacology of corticosteroids for diabetic macular edema","volume":"59","author":"Whitcup","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2022.03.079_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1176","article-title":"PEDF: a multifaceted neurotrophic factor","volume":"4","author":"Tombran-Tink","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2022.03.079_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrc3484","article-title":"The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential","volume":"13","author":"Becerra","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2022.03.079_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.03.079_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization","volume":"188","author":"Mori","year":"2001","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.bbrc.2022.03.079_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ophtha.2005.10.030","article-title":"Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema","volume":"113","author":"Funatsu","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbrc.2022.03.079_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2005.10.002","article-title":"Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: implications for structural differences in macular profiles","volume":"82","author":"Patel","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2022.03.079_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0002-9394(02)01549-0","article-title":"Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration","volume":"134","author":"Holekamp","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2022.03.079_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-9255-8-38","article-title":"Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series","volume":"8","author":"Noma","year":"2011","journal-title":"J.\u00a0Inflamm."},{"key":"10.1016\/j.bbrc.2022.03.079_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/978-3-319-17121-0_93","article-title":"Pigment epithelium-derived factor, a protective factor for photoreceptors in\u00a0vivo","volume":"854","author":"Polato","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2022.03.079_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2019.04.008","article-title":"PEDF peptides promote photoreceptor survival in rd10 retina models","volume":"184","author":"Hern\u00e1ndez-Pinto","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2022.03.079_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oret.2020.09.024","article-title":"Patient-reported complications after intravitreal injection and their predictive factors","volume":"5","author":"Ramos","year":"2020","journal-title":"Ophthalmol. Retin."},{"key":"10.1016\/j.bbrc.2022.03.079_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-4835(83)90043-X","article-title":"Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit","volume":"36","author":"Laurent","year":"1983","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2022.03.079_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14837","article-title":"Long-acting protein drugs for the treatment of ocular diseases","volume":"8","author":"Ghosh","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2022.03.079_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bjo.2006.110890","article-title":"Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy","volume":"91","author":"Yokoi","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrc.2022.03.079_bib19","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/pro.5560051220","article-title":"Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells","volume":"5","author":"Stratikos","year":"1996","journal-title":"Protein Sci"},{"key":"10.1016\/j.bbrc.2022.03.079_bib20","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1073\/pnas.211268598","article-title":"Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor","volume":"98","author":"Simonovic","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2022.03.079_bib21","doi-asserted-by":"crossref","first-page":"25241","DOI":"10.1074\/jbc.M115.645846","article-title":"Small retinoprotective peptides reveal a receptor-binding region on pigment epithelium-derived factor","volume":"290","author":"Kenealey","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.079_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107798","article-title":"Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization","volume":"188","author":"Sheibani","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2022.03.079_bib23","doi-asserted-by":"crossref","first-page":"33310","DOI":"10.1074\/jbc.M801287200","article-title":"Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site","volume":"283","author":"Becerra","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.079_bib24","doi-asserted-by":"crossref","first-page":"W239","DOI":"10.1093\/nar\/gkl190","article-title":"CUPSAT: prediction of protein stability upon point mutations","volume":"34","author":"Parthiban","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bbrc.2022.03.079_bib25","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","article-title":"SIFT web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bbrc.2022.03.079_bib26","doi-asserted-by":"crossref","first-page":"10643","DOI":"10.1021\/bi9802317","article-title":"Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site","volume":"37","author":"Alberdi","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2022.03.079_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/002215549704500813","article-title":"Patterns of hyaluronan staining are modified by fixation techniques","volume":"45","author":"Lin","year":"1997","journal-title":"J.\u00a0Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"10.1016\/j.bbrc.2022.03.079_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/jpet.112.192575","article-title":"Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization","volume":"342","author":"Bai","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2022.03.079_bib29","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1074\/jbc.M507401200","article-title":"Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1","volume":"281","author":"Cai","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.03.079_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/j.1460-2075.1994.tb06261.x","article-title":"Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein","volume":"13","author":"Yang","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.bbrc.2022.03.079_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2022.03.079_bib32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","article-title":"Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives","volume":"24","author":"Bordet","year":"2019","journal-title":"Drug Discov. Today"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22004120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22004120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:17:15Z","timestamp":1757765835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22004120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"alternative-id":["S0006291X22004120"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.079","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pigment epithelium-derived factor engineered to increase glycosaminoglycan affinity while maintaining bioactivity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}